CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the last few months. He told investors to keep …
Robert Galbraith | Reuters The Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement – a move …
My top 10 things to watch Friday, August 4: 1. [Club name] Amazon’s (AMZN) second-quarter results on Thursday gave investors exactly what they wanted. The ecommerce giant dramatically brought down …